title: Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy.
authors.affiliation: Medical College of Wisconsin, Milwaukee, USA.
authors.forename: P S
authors.initials: PS
authors.lastname: Ritch
authors.forename: C
authors.initials: C
authors.lastname: Keever
authors.forename: J
authors.initials: J
authors.lastname: Schiller
authors.forename: S
authors.initials: S
authors.lastname: Rivkin
authors.forename: P L
authors.initials: PL
authors.lastname: Witt
authors.forename: S E
authors.initials: SE
authors.lastname: Grossberg
authors.forename: R L
authors.initials: RL
authors.lastname: Truitt
authors.forename: H
authors.initials: H
authors.lastname: Burris
authors.forename: D D
authors.initials: DD
authors.lastname: von Hoff
authors.forename: L
authors.initials: L
authors.lastname: Vaickus
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D004334:Drug Administration Schedule; D006031:Glycosylation; D006801:Humans; D015850:Interleukin-6 / Q000008:administration & dosage* / Q000737:chemistry; D009369:Neoplasms / Q000188:drug therapy*; D011994:Recombinant Proteins
chemical_list: D000970:Antineoplastic Agents; D015850:Interleukin-6; D011994:Recombinant Proteins